Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children. Issue 1 (January 2022)

• Record Type: Journal Article
• Authors: Morin, Sébastien; Lallemant, Marc; Garcia-Prats, Anthony; Lewis, Linda; Watkins, Melynda; Giaquinto, Carlo; Valentin, Marie; Penazzato, Martina; Reeder, John C.
• Is Part Of: Pediatric infectious disease journal. Volume 41:Issue 1(2022)
• Publication Date: 2022-01
• Subjects: Pediatrics -- COVID-19 -- SARS-CoV-2 -- therapeutics -- research and development; Communicable diseases in children -- Periodicals; Infection in children -- Periodicals; 618.929
• DOI: 10.1097/INF.0000000000003331
• Languages: English
• ISSNs: 0891-3668

Abstract

Abstract : Children, although at lower risk of poor outcomes from COVID-19 relative to adults, still stand to benefit from therapeutic interventions. Understanding of COVID-19 clinical presentation and prognosis in children is essential to optimize therapeutic trials design. This perspective illustrates how to collectively accelerate pediatric COVID-19 therapeutic research and development, based on the experience of the Global Accelerator for Paediatric Formulations.